Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

Programmed death-ligand 1 (PD-L1) expression in tumor tissue is under investigation as a candidate biomarker in immuno-oncology dug development. The soluble form of PD-L1 (sPDL1) is suggested to have immunosuppressive activity. In this study, we measured the serum level of sPDL1 and evaluated its pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Hyerim, Nam, Ah-Rong, Bang, Ju-Hee, Park, Ji-Eun, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363533/
https://www.ncbi.nlm.nih.gov/pubmed/27780932
http://dx.doi.org/10.18632/oncotarget.12810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363533/
https://www.ncbi.nlm.nih.gov/pubmed/27780932
http://dx.doi.org/10.18632/oncotarget.12810

Ejemplares similares